Boston Scientific Corporation to Acquire Intera Oncology Inc., Expanding Cancer Treatment Portfolio
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has announced a definitive acquisition agreement...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity